Arax Advisory Partners’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158K Sell
7,610
-1,783
-19% -$42K ﹤0.01% 2418
2026
Q1
$214K Buy
9,393
+8,296
+756% +$196K 0.01% 1052
2025
Q4
$29.2K Buy
+1,097
New +$32.4K ﹤0.01% 1910
2025
Q3
Sell
-775
Closed -$24.3K 3793
2025
Q2
$24.3K Sell
775
-221
-22% -$7.31K ﹤0.01% 1568
2025
Q1
$38.1K Buy
996
+982
+7,014% +$41.7K ﹤0.01% 1055
2024
Q4
$615 Buy
+14
New +$615 ﹤0.01% 2282

Other funds holding ENOV

Arax Advisory Partners's ENOV Position: Q2 2026 in Review

Arax Advisory Partners reduced its Enovis (ENOV) stake by 19% in Q2 2026, selling an estimated $42K and leaving 7,610 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

Arax Advisory Partners first reported a position in ENOV in Q4 2024 and has held it in 6 quarters since. The position peaked at $214K in Q1 2026. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Arax Advisory Partners held 7,610 shares of Enovis worth $158K as of Q2 2026.
  • Arax Advisory Partners sold 1,783 Enovis shares in Q2 2026, an estimated $42K.
  • Enovis made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2418 holding.
  • Arax Advisory Partners first reported a position in Enovis in Q4 2024 and has held it in 6 quarters since.
  • Arax Advisory Partners's Enovis position peaked at $214K in Q1 2026.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.